99mTc labeled levofloxacin as an infection imaging agent: A novel method for labeling levofloxacin using cysteine•HCl as co-ligand and in vivo study

Turkish Journal of Chemistry

Volumn 36, Issue 2, 2012, Pages 267-277

  Naqvi, Syed Ali Raza ^a   Ishfaq, Malik Muhammad ^b   Khan, Zulfiqar Ali ^a   Nagra, Saeed Ahmad ^c   Bukhari, Iftikhar Hussain ^a   Hussain, Abdullah Ijaz ^a   Mahmood, Nasir ^d   Shahzad, Sohail Anjum ^e   Haque, Asma ^a   Bokhari, Tanveer Hussain ^a  

^a GOVERNMENT COLLEGE UNIVERSITY   (Pakistan)

^b PAKISTAN INSTITUTE OF NUCLEAR SCIENCE AND TECHNOLOGY   (Pakistan)

^c UNIVERSITY OF THE PUNJAB   (Pakistan)

^d UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

^e COMSATS Institute of Information Technology ^*  (Pakistan)

Author keywords

99mTc levofloxacin; Biodistribution; Co ligand; Infection; Infection model; Scintigraphy

Indexed keywords

EID: 84858827857     PISSN: 13000527     EISSN: 13036130     Source Type: Journal    
DOI: 10.3906/kim-1107-69     Document Type: Article

References (24)

1. Naqvi, S. A. R.; Matzow, T.; Finucane, C.; Nagra, S. A.; Ishfaq, M. M.; Mather, S. J.; Sosabowski, J. Cancer Biotherapy & Radiopharmaceuticals 2010, 25, 89-95.
2. von Guggenberg, E.; Dietrich, H.; Skvortsova, I.; Gabriel, M.; Virgolini, I. J.; Decristoforo, C. Eur. J. Nucl. Med. Mol. Imaging 2007, 34, 1209-1218
3. Signore, A.; Annovazzi, A.; Barone, R.; Bonanno, E.; D'Alessandria, C.; Chianelli, M.; Mather, S. J.; Bottoni, U.; Panetta, C.; Innocenzi, D.; Scopinaro, F.; Calvieri, S. J. Nucl. Med. 2004, 45, 1647-1652.
4. Santin, M.; Podzamczer, D.; Ricart, I.; Mascaŕo, J.; Raḿon, J. M.; Dominguez, A.; Rufí, G.; Gudiol, A. F. Clin. Infect. Dis. 1995, 20, 652-656.
5. Froelich, J. W.; Swanson, D. Semin. Nucl. Med. 1984; 14: 128-140.
6. Buscombe, J. R.; Lui, D.; Ensing, G.; de Jong, R.; Ell, P. J. Eur. J. Nucl. Med. 1990; 16: 649-655
7. Bhatnagar, A.; Singh, A. K.; Singh, T.; Shankar, L. R. Nuclear Medicine Communications 1995, 16, 1052-1062
8. Flivik, G.; Sloth, M.; Rydholm, U.; Herrlin, K.; Lidgren, L. J. Nucl. Med. 1993, 34, 1646-1650.
9. Seral, C.; Barcia-Macay, M.; Mingeot-Leclercq, M. P.; Tulkens, P. M.; Bambeke, F. V. J. Antimicrob. Chemother. 2005, 55, 511-517.
10. Wagenlehner, F. M. E.; Krieger, J. N. Pelviperineology 2011, 30, 17-26.
11. Carratal̀a, J.; Garcia-Vidal, C. Curr Opin Infect Dis 2010, 23, 152-157.
12. Falćo, V.; Molina, I.; Juste, C.; Crespo, M.; Almirante, B.; Pigrau, C.; Ferrer, A.; Bravo, C.; Palomar, M.; Pahissa, A. Enferm. Infecc. Microbiol. Clin. 2006, 24, 360-364.
13. Griffin, A. T.; Peyrani, P.; Wiemken, T.; Arnold, F. Int J Tuberc Lung Dis 2010, 14, 495-499.
14. Pedro-Botet, M. L.; Garća-Cruz, A.; Tural, C.; Mateu, L.; Sopena, N.; Roure, S.; Rey-Joly, C.; Sabria, M. J. Chemother. 2006, 18, 559-561.
15. Drago, L.; De Vecchi, E.; Mombelli, B.; Nicola, L.; Valli, M.; Gismondo, M. R. J. Antimicrob. Chemother. 2001, 48, 37-45
16. Solanki, K. K.; Bomanji, J.; Siraj, Q.; Small, M.; Britton, K. E. J. Nucl. Med. 1993, 34, 119P.
17. Shimpi, H. H.; Nair, N. Indian J. Nucl. Med. 2003, 18, 16.
18. EL-Ghany; Amin, E. A.; Kawy, A. M.; Amin, O. A. Journal of Labelled Compounds and Radiopharmaceuticals 2007, 50, 25-31.
19. Ibrahim, I. T.; Motaleb, M. A.; Attalah, K. M. Journal of Radioanalytical and Nuclear Chemistry 2010, 285, 431-436
20. Siaens, R. H.; Rennen, H. J.; Boerman, O. C.; Dierckx, R.; Slegers, G. J. Nucl. Med. 2004, 45, 2088-2094.
21. Singh, A. K.; Verma, J.; Bhatnagar, A.; Ali, A. World J. Nucl. Med. 2003, 103-109.
22. Wolfson, J. S.; Hooper, D. C. AntimicrobialAgents and Chemotherapy 1985, 28, 581-586.
23. Evans, M. E.; Titlow, W. B. J. Antimicrob. Chemother. 1998, 41, 285-288.
24. Wimer, S. M.; Schoonover, L.; Garrison, M. W. Clin Ther, 1998, 20, 1049-1070.